Efficacy of a Unani formulation in Bronchial Asthma

Phase 4

Completed

• Conditions: Health Condition 1: null- Diagnosed case of Bronchial AsthmaHealth Condition 2: J454- Moderate persistent asthma

• Registration Number: CTRI/2018/07/015124
• Lead Sponsor: IUM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-01-03
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

•Mild (PEF >= 70 %) and moderate asthma (PEF 40â??69 %) 12.

• Patients belonging to 18-60 years of age of both genders.

Exclusion Criteria

•Severe asthma

• Received sympathomimetic or anticholinergic bronchodilator with in 24 hrs

prior to enrollment

• Patients with known systemic and metabolic disorders

• Pregnant and lactating women

• A history of sensitivity to β-agonists

Study & Design

• Study Type: Interventional
• Study Design: Not specified